EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-functional magnetic resonance imaging predicts for clinico-pathological response to neoadjuvant chemotherapy in primary breast cancer



Multi-functional magnetic resonance imaging predicts for clinico-pathological response to neoadjuvant chemotherapy in primary breast cancer



Breast Cancer Research & Treatment 82(Supplement 1): S59




(PDF 0-2 workdays service: $29.90)

Accession: 035349227

Download citation: RISBibTeXText



Related references

Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clinical Cancer Research 14(20): 6580-6589, 2008

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype. Springerplus 5: 152-152, 2016

Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer. Investigative Radiology 50(4): 195-204, 2015

Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy. Journal of Clinical Oncology 25(35): 5667-5669, 2007

Prediction of pathological complete response to neoadjuvant chemotherapy by magnetic resonance imaging in breast cancer patients. Breast 24(2): 159-165, 2015

Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response?. Annals of Surgical Oncology 15(12): 3609-3613, 2009

Role of magnetic resonance imaging for response evaluation and predictive value of tumor biomarkers in the neoadjuvant chemotherapy for breast cancer:a multi-center prospective study. Zhonghua Yi Xue Za Zhi 94(26): 2018-2021, 2015

Nottingham Clinico-Pathological Response Index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer. Clinical Cancer Research 21(5): 1052-1062, 2016

Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging. Japanese Journal of Radiology 28(2): 101-109, 2010

Magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity. Journal of Computer Assisted Tomography 36(2): 200-206, 2012

Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. Journal of Clinical Oncology 29(6): 660-666, 2011

Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer. European Radiology: -, 2016

Relevance of breast cancer subtypes for magnetic resonance imaging response monitoring during neoadjuvant chemotherapy. Clinical & Translational Oncology 14(6): 486-488, 2013

Correlation between magnetic resonance imaging and histopathological tumor response after neoadjuvant chemotherapy in breast cancer. Tumori 94(4): 481-488, 2008

Evaluation of pathologic response of breast cancer to neoadjuvant chemotherapy with magnetic resonance diffusion weighted imaging. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 31(6): 1336-1341, 2015